Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
12.80B | 12.75B | 13.12B | 15.31B | 14.18B | 13.77B | Gross Profit |
4.48B | 12.75B | 4.28B | 4.62B | 4.56B | 4.73B | EBIT |
1.69B | 1.87B | 1.50B | 1.64B | 1.75B | 1.76B | EBITDA |
1.89B | 1.87B | 1.76B | 1.64B | 2.05B | 2.25B | Net Income Common Stockholders |
1.00B | 1.34B | 951.00M | 960.00M | 1.49B | 1.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
694.00M | 694.00M | 274.00M | 299.00M | 286.00M | 435.00M | Total Assets |
15.63B | 15.63B | 15.62B | 18.50B | 18.18B | 18.00B | Total Debt |
6.34B | 6.34B | 6.53B | 7.17B | 7.73B | 8.11B | Net Debt |
5.65B | 5.65B | 6.25B | 6.87B | 7.44B | 7.68B | Total Liabilities |
11.75B | 11.75B | 12.25B | 14.12B | 13.96B | 14.36B | Stockholders Equity |
3.77B | 3.77B | 3.17B | 3.94B | 3.72B | 3.11B |
Cash Flow | Free Cash Flow | ||||
927.00M | 1.76B | 968.00M | 1.16B | 1.15B | 1.48B | Operating Cash Flow |
1.54B | 1.76B | 1.65B | 1.65B | 1.70B | 1.99B | Investing Cash Flow |
-679.00M | -750.00M | -562.00M | -448.00M | -528.00M | -585.00M | Financing Cash Flow |
-1.41B | -607.00M | -1.11B | -1.08B | -1.31B | -1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $84.45B | 19.07 | 17.12% | 2.72% | 1.18% | -5.47% | |
75 Outperform | $6.41B | 19.24 | 10.08% | ― | 7.32% | 34.44% | |
73 Outperform | $28.43B | 21.22 | 35.58% | 2.73% | -16.16% | 41.01% | |
72 Outperform | $33.70B | 13.30 | 28.29% | 3.85% | -1.48% | 11.45% | |
70 Outperform | $12.02B | 21.96 | 14.94% | 3.63% | 6.34% | -30.58% | |
68 Neutral | $37.43B | 13.87 | 5.58% | 5.11% | -2.98% | -2.22% | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% |
On February 21, 2025, Kellanova’s Board of Directors made compensation decisions for its executive officers, involving the issuance of restricted stock units (RSUs). The independent board members approved RSU grants for several executives, with vesting conditions set for three years from the grant date. This move reflects Kellanova’s commitment to aligning executive compensation with long-term company performance, potentially impacting stakeholder interests by incentivizing leadership to focus on sustained growth.
Kellanova, a Delaware corporation, has entered into a new unsecured 364-Day Credit Facility with a consortium of major banks, allowing it to borrow up to $750 million. This agreement replaces an existing facility and includes customary financial covenants and events of default. The move is expected to enhance the company’s financial flexibility and maintain its strong market positioning, with no borrowings outstanding under the new arrangement at the time of the announcement.